All In Biotech

Drug Trial Radar · NCT06638307

A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer

A Phase 1, First-in-Human Study of MEN2312, a KAT6 Inhibitor, as Monotherapy and in Combination in Participants With Advanced Breast Cancer

Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 240 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

240

Planned (sponsor's estimate)

Start

Oct 25, 2024

Primary completion

Oct 24, 2027

Study completion Oct 23, 2029

Sponsor

Lead sponsor
Stemline Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Oct 15, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a first-in-human study of MEN2312, a lysine acetyltransferase 6 (KAT6) inhibitor, in adult participants with advanced breast cancer.

Conditions

  • Advanced Breast Cancer

Interventions

  • MEN2312Drug

    MEN2312 administered as oral tablets.

  • ElacestrantDrug

    Elacestrant administered as oral tablets.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants Experiencing Dose-limiting Toxicity When Administered MEN2312Time frame: Baseline through Day 28
  2. Recommended Phase 2 Dose (RP2D) of MEN2312Time frame: Baseline through Month 6

Locations

47 sites in 2 countries. Site status is shown where the registry gives one.

  • Highlands Oncology Group

    Springdale, Arkansas · Recruiting

  • City of Hope

    Duarte, California · Recruiting

  • UC San Diego Moores Cancer Center

    La Jolla, California · Recruiting

  • Stanford Cancer Center

    Palo Alto, California · Recruiting

  • UCSF Helen Diller Family Comprehensive Cancer Center

    San Francisco, California · Recruiting

  • UCLA Hematology Oncology - Parkside

    Santa Monica, California · Recruiting

  • Yale Comprehensive Cancer Center

    New Haven, Connecticut · Recruiting

  • Advent Health Orlando

    Altamonte Springs, Florida · Recruiting

  • Sarah Cannon Research Institute at Florida Cancer Specialists

    Orlando, Florida · Recruiting

  • Florida Cancer Specialists & Research Institute (FCS) - Sarasota

    Sarasota, Florida · Recruiting

  • Moffitt Cancer Center

    Tampa, Florida · Recruiting

  • Winship Cancer Institute, Emory University

    Atlanta, Georgia · Recruiting

  • University of Illinois Hospital and Health Sciences System (Outpatient Cancer Center)

    Chicago, Illinois · Recruiting

  • University of Chicago Medical Center

    Chicago, Illinois · Recruiting

  • University of Iowa Health Care

    Iowa City, Iowa · Recruiting

  • The University of Kansas Cancer Center

    Fairway, Kansas · Recruiting

  • Sidney Kimmel Comprehensive Cancer Center

    Baltimore, Maryland · Recruiting

  • Massachusetts General Hospital Cancer Center

    Boston, Massachusetts · Recruiting

  • Dana-Farber Cancer Institute

    Boston, Massachusetts · Recruiting

  • START Midwest - Oncology

    Grand Rapids, Michigan · Recruiting

  • Mayo Clinic

    Rochester, Minnesota · Recruiting

  • Astera Cancer Care

    East Brunswick, New Jersey · Recruiting

  • Perlmutter Cancer Center - Sunset Park

    Brooklyn, New York · Recruiting

  • Perlmutter Cancer Center at NYU Langone Hospital - Long Island

    Mineola, New York · Recruiting

  • Laura & Isaac Perlmutter Cancer Center at NYU Langone Health

    New York, New York · Recruiting

  • Memorial Sloan Kettering Cancer Center

    New York, New York · Recruiting

  • Providence Cancer Institute Franz Clinic

    Portland, Oregon · Recruiting

  • The West Clinic, PC dba West Cancer Center

    Germantown, Tennessee · Recruiting

  • SCRI Oncology Partners Group

    Nashville, Tennessee · Recruiting

  • University of Texas Southwestern Medical Center

    Dallas, Texas · Recruiting

  • The University of Texas M.D. Anderson Cancer Center

    Houston, Texas · Recruiting

  • START San Antonio, LLC

    San Antonio, Texas · Recruiting

  • University of Texas Health Science Center San Antonio

    San Antonio, Texas · Recruiting

  • START Mountain

    West Valley City, Utah · Recruiting

  • NEXT Virginia

    Fairfax, Virginia · Recruiting

  • University of Wisconsin Carbone Cancer Center

    Madison, Wisconsin · Recruiting

  • Froedtert Hospital & the Medical College of Wisconsin

    Milwaukee, Wisconsin · Recruiting

  • Maria Martinez Garcia

    Barcelona, Spain · Recruiting

  • Hospital Universitario Vall d'Hebron - Vall d'Hebron Institute of Oncology (VHIO) Medical Oncology Department

    Barcelona, Spain · Recruiting

  • IOB - Madrid Fundacion Hermanas Hospitalarias (Hospital Beata Maria Ana)

    Madrid, Spain · Recruiting

Showing 40 of 47 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.